Rein Therapeutics Inc. (RNTX) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 1.30 |
| Altman Z-Score | -28.34 (distress) |
| Sector P/E (Healthcare) | 21.7 |
RNTX overview · RNTX earnings · RNTX KPIs · RNTX investor relations · RNTX ownership · RNTX peers · RNTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.